iBio Inc (USD)
IBIO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.25 | 0.32
52-Wk Range0.05 | 1.40
Last Close0.28
Mkt Cap (m)8.88
Dividend yield-
ISINUS4510332038
Volume117
Exchange VenueASE

Company Profile

iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales2.66
P/CF-
Rev Growth (3 year avg)28.64
EPS Growth (3 year avg)-
Operating Margin % -782.36
Net Margin %-871.80
Return on Equity-191.67
Debt/Equity10.10

Legal Documents

Prospectus
en 28/10/2019
Annual Report
en 30/06/2019

Financials

Income Statement
USD201320142015201620172018
Revenue (m)121
Operating Income (m)-7-4-7-10-14-14
Net Income (m)-6-4-7-10-15-16
Basic EPS-1.30-0.60-0.90-1.20-1.60-1.54
Avg. Diluted Shares Outstanding (m)5678911
Balance Sheet
USD201320142015201620172018
Current Assets (m)741024916
Non Current Assets (m)332282727
Total Assets (m)9612523643
Current Liabilities (m)41222
Total Liabilities (m)------
Total Equity (m)561110916
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-5-4-5-8-13-13
Capital Expenditure (m)-2-1
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
0.28
Last Price